“We also expect, Scott, to unveil the plans of Quantinuum in the Q4 time frame.”

In context

“And then actually, as we speak, we are doing the fundraise, so that we could capitalize the company between now and the IPO time. To your specific question, I think we are looking at more commercial evidence, which can prove the revenue stream for it. We had a big win in Qatar when President was visiting there. There was a big announcement that Qatar is going to invest for Quantum infrastructure. So wins like that give the investor confidence on the full revenue stream. And the way I see time line today is end of '27 is, I would say, the outline at the most. Can we pull it forward by a couple of months or quarter? Yes, that possibility always remains. So we're working with that kind of time line. And we do have a good visibility on commercial progress between now and then to execute that. We also expect, Scott, to unveil the plans of Quantinuum in the Q4 time frame. So we'll keep all our shareowners informed on some of the progress we are making, and we'll share that on a more broader basis. Scott Reed Davis: Okay. That's helpful, Vimal. And just to switch to the R&D. It's -- and we don't have to make a big deal out of this. But the timing, I don't think I've ever seen a company prior to a breakup increase R&D spend. So I'm just kind of curious, is that a message coming from the businesses that they felt like they were behind? Or is there just -- it just happened to be a little bit of just -- it is what it is? I'll just stop there. I don't want to make... Vimal M. Kapur: This is part of the message I've been saying since last year that Honeywell organic growth with the strength of improving our fundamentals. So the 2 fundamentals we were focused on i”